1 documents found
Information × Registration Number 0204U006840, 0102U003049 , R & D reports Title To study antituberculous activity of rifabutin and flurenizid and to work out the effective regimens of chemotherapy with using these drugs in patients with destructive pulmonary tuberculosis popup.stage_title Head Byalik Y.B., Registration Date 24-12-2004 Organization Institute of tuberculosis and pulmonology named by F.G. Yanovsky popup.description2 Object: 58 strains of Mycobacterium tuberculosis (MBT) and 244 patients with destructive lung tuberculosis. The high bacteriostatic activity and efficacy of rifabutin (Rb) and flurenizid (Fl), partial cross MBT resistance between Rb and rifampicin and fool between Fl and isoniazid (H), the best Fl tolerance than H, advisability of Rb using every other day were established. Application sphere - phthisiology Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
To study antituberculous activity of rifabutin and flurenizid and to work out the effective regimens of chemotherapy with using these drugs in patients with destructive pulmonary tuberculosis
Head: Byalik Y.B.. To study antituberculous activity of rifabutin and flurenizid and to work out the effective regimens of chemotherapy with using these drugs in patients with destructive pulmonary tuberculosis. (popup.stage: ). Institute of tuberculosis and pulmonology named by F.G. Yanovsky. № 0204U006840
1 documents found

Updated: 2026-03-26


Роздрукувати цю сторінку